`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`APOTEX INC, APOTEX CORP., APOTEX PHARMACEUTICALS
`HOLDINGS INC., and APOTEX HOLDINGS, INC.,
`Petitioners,
`
`V.
`
`OSI PHARMACEUTICALS, INC.,
`Patent Owner.
`
`Case IPR2016—01284
`
`U.S. Patent No. 6,900,221
`
`OSI PHARMACEUTICALS, LLC’S UPDATED POWER OF ATTORNEY
`
`UNDER 37 C.F.R. § 42.10
`
`
`
`IPR20 16-01 284
`
`U.S. Patent No. 6,900,221
`
`Patent Owner OSI Pharmaceuticals, LLC (“O81”), the successor in interest
`
`to O81 Pharmaceuticals, lno, hereby appoints the following attorneys andfor
`
`agents to prosecute the above captioned inter panes review and transact all
`
`business in the US. Patent and Trademark Office connected herewith:
`
`0 All practitioners at Customer Number 23483
`
`0 Amy K. Wigrnore
`
`Please address all communications to:
`
`Wilmer Cutler Pickering Hale and Dorr LLP
`60 State St.
`
`Boston, MA 02109
`Telephone: 617-526-6000
`Facsimile: 6l7—526~5000
`
`Please address all e—mails and telephone calls to lead and back-up counsel,
`
`as identified below and in Patent Owner’s Updated Mandatory Notices:
`
`0 Lead Counsel:
`
`Emily Whelan, Reg. No. 50,391
`Emily.Whe1an@wi1n1erha1e.corn
`Telephone: 617-526-6567
`
`0 Back—up Counsel:
`
`Jonathan B. Roses, Reg. No. 61,115
`Jonathan.Roses@wiirnerhale.com
`Telephone: 617-526-6048
`
`Kevin M. Ynrkerwich, Reg. No. 71,195
`Kevin.Yurkerwich@wi1rnerha1e.eorn
`Telephone: 61 7=-3266456
`
`
`
`IPRZO l 6~Ol 284
`
`U.S. Patent No. 6,900;221
`
`Amy K. Wigmore
`Amy.Wigm0re@wilmerhale.c0m
`Telephone: 202-663—-6096
`
`The individual listed below has the authority to execute this document on
`
`behalf of OSI.
`
`For: OSI
`
`
`
`%’ V’
`
`V
`
`Name:
`
`Linda F. Friedman
`
`Title:
`
`Secretary
`
`Dated:
`
`35/5*‘ 55;’ 2
`
`